tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CMRX

CMRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Pre-EarningsCMRX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
CMRX
Chimerix Terminates Loan and Delists from Nasdaq
PremiumCompany Announcements
Chimerix Terminates Loan and Delists from Nasdaq
2M ago
8K
CMRX
Chimerix Reports 2024 Losses Amid Acquisition News
PremiumCompany Announcements
Chimerix Reports 2024 Losses Amid Acquisition News
3M ago
CMRX
Chimerix Hold Rating: Acquisition by Jazz Pharmaceuticals and Uncertain Clinical Prospects Justify Caution
PremiumRatings
Chimerix Hold Rating: Acquisition by Jazz Pharmaceuticals and Uncertain Clinical Prospects Justify Caution
3M ago
CMRX
Chimerix reports Q4 EPS (25c), consensus (28c)
PremiumThe Fly
Chimerix reports Q4 EPS (25c), consensus (28c)
3M ago
CMRX
Chimerix Hold Rating: Financial Constraints and Revised EPS Outlook Influence Cautious Recommendation
PremiumRatingsChimerix Hold Rating: Financial Constraints and Revised EPS Outlook Influence Cautious Recommendation
4M ago
CMRX
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
4M ago
BCS
LAC
Jazz Pharmaceuticals price target raised to $230 from $220 at Truist
Premium
The Fly
Jazz Pharmaceuticals price target raised to $230 from $220 at Truist
4M ago
CMRX
JAZZ
Chimerix Stock Hold Rating: Limited Upside Due to Acquisition Offer Price Alignment
PremiumRatings
Chimerix Stock Hold Rating: Limited Upside Due to Acquisition Offer Price Alignment
4M ago
CMRX
Chimerix downgraded to Hold from Buy at JonesResearch
PremiumThe Fly
Chimerix downgraded to Hold from Buy at JonesResearch
4M ago
CMRX
Strategic Acquisition and NDA Submission Boost Chimerix’s Market Potential
PremiumRatings
Strategic Acquisition and NDA Submission Boost Chimerix’s Market Potential
4M ago
CMRX
Cautious Outlook on Chimerix Amid Acquisition and Uncertainties in Drug Approval
PremiumRatings
Cautious Outlook on Chimerix Amid Acquisition and Uncertainties in Drug Approval
4M ago
CMRX
Chimerix downgraded to Hold from Buy at Jefferies
PremiumThe FlyChimerix downgraded to Hold from Buy at Jefferies
4M ago
CMRX
CrowdStrike reports Q4 beat, Jazz to acquire Chimerix: Morning Buzz
Premium
The Fly
CrowdStrike reports Q4 beat, Jazz to acquire Chimerix: Morning Buzz
4M ago
FL
ANF
Hold Rating Issued Amidst Chimerix Acquisition by Jazz Pharmaceuticals
Premium
Ratings
Hold Rating Issued Amidst Chimerix Acquisition by Jazz Pharmaceuticals
4M ago
CMRX
Chimerix downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Chimerix downgraded to Neutral from Buy at H.C. Wainwright
4M ago
CMRX
Chimerix downgraded to Neutral from Outperform at Wedbush
PremiumThe Fly
Chimerix downgraded to Neutral from Outperform at Wedbush
4M ago
CMRX
Chimerix Merges with Jazz Pharmaceuticals in $935M Deal
PremiumCompany Announcements
Chimerix Merges with Jazz Pharmaceuticals in $935M Deal
4M ago
8K
CMRX
Jazz Pharmaceuticals to acquire Chimerix for $8.55 per share in cash
PremiumThe Fly
Jazz Pharmaceuticals to acquire Chimerix for $8.55 per share in cash
4M ago
CMRX
JAZZ
Jazz Pharmaceuticals to acquire Chimerix for $8.55 per share in cash, or $935M
PremiumThe FlyJazz Pharmaceuticals to acquire Chimerix for $8.55 per share in cash, or $935M
4M ago
CMRX
JAZZ
Jazz Pharmaceuticals to acquire Chimerix for $8.55 per share in cash
Premium
The Fly
Jazz Pharmaceuticals to acquire Chimerix for $8.55 per share in cash
4M ago
CMRX
JAZZ
Chimerix’s Strategic Pause and Financial Strength Bolster Long-term Buy Rating Amid Regulatory Milestones
Premium
Ratings
Chimerix’s Strategic Pause and Financial Strength Bolster Long-term Buy Rating Amid Regulatory Milestones
4M ago
CMRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >